• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

New Pediatric Labeling Information Database - Detail

  • Print
  • Share
  • E-mail
Pediatric Labeling Date:  03/11/2005
Trade Name:  Xopenex HFA Inhalation Aerosol
Generic Name or Proper Name (*):  levalbuterol
Indications Studied:  Treatment of bronchospasm in patients with reversible obstructive airway disease in children 4 years of age and older
Label Changes Summary:  * Extended indication for use in children down from 6 years of age * Pediatric patients have a lower exposure to the drug than adults * Population PK model developed from patients down to 4 years of age * Effectiveness and safety established from studies in adults, adolescents (12 years of age and older) and children ages 4-11 years of age with asthma. * Deferred studies in patients < 4 years of age * New active ingredient
Product Labeling:  Labeling  Opens a new window
Sponsor:  Sepracor
Therapeutic Category:  Antiasthmatic